Considerations towards a population health approach to reduce prescription opioid-related harms (with a primary focus on Canada)

References

• Babor, T., Caetano, R., Casswell, S., Edwards, G., & Giesbrecht, N. (2010). Alcohol: No ordinary commodity: Research and public policy. London: Oxford University Press
   Google Scholar
• Bachs, L.C., Engeland, A., Mørland, J.G., & Skurtveit, S. (2009). The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clinical Pharmacology and Therapeutics, 85, 596–599
   PubMed Web of Science ®Google Scholar
• Ballantyne, J.C., & Shin, N.S. (2008). Efficacy of opioids for chronic pain: A review of the evidence. The Clinical Journal of Pain, 24, 469–478
   PubMed Web of Science ®Google Scholar
• Banta-Green, C.J., Maynard, C., Koepsell, T.D., Wells, E.A., & Donovan, D.M. (2009). Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction, 104, 775–783
   PubMed Web of Science ®Google Scholar
• Bloor, R.N., McAuley, R., & Smalldridge, N. (2005). Safe storage of methadone in the home—An audit of the effectiveness of safety information giving. Harm Reduction Journal, 2, 9
   PubMedGoogle Scholar
• Brennan, F., Carr, D.B., & Cousins, M. (2007). Pain management: A fundamental human right. Anesthesia and Analgesia, 105, 205–221
   PubMed Web of Science ®Google Scholar
• British Columbia Ministry of Health. (2010). Healthy minds, healthy people: A 10-year plan to address mental health and substance use in British Columbia. Vancouver, BC: Ministry of Health Services and Ministry of Children and Family Development
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2012). Community-based opioid overdose prevention programs providing naloxone, United States, 2010. MMWR Morbidity and Mortality Weekly Report, 61, 101–105
   PubMedGoogle Scholar
• Chou, R. (2009). 2009 clinical guidelines from the American pain society and the American academy of pain medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice? Polskie Archiwum Medycyny Wewnetrznej, 119, 469–476
   PubMed Web of Science ®Google Scholar
• Chou, R., Ballantyne, J.C., Fanciullo, G.J., Fine, P.G., & Miaskowski, C. (2009). Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American pain society and American academy of pain medicine clinical practice guideline. The Journal of Pain, 10, 147–159
   PubMed Web of Science ®Google Scholar
• Dasgupta, N., Kramer, E.D., Zalman, M.A., Carino, S., Smith, M.Y., Haddox, J. D.… Wright, C 4th. (2006). Association between non-medical and prescriptive usage of opioids. Drug & Alcohol Dependence, 82, 135–142
   PubMed Web of Science ®Google Scholar
• Dhalla, I.A., Mamdani, M.M., Gomes, T., & Juurlink, D.N. (2011). Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. Canadian Family Physician, 57, e92–e96
   PubMed Web of Science ®Google Scholar
• Dhalla, I.A., Mamdani, M.M., Sivilotti, M.L., Kopp, A., Qureshi, O., & Juurlink, D.N. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Canadian Medical Association Journal, 181, 891–896
   PubMed Web of Science ®Google Scholar
• Edlund, M.J., Martin, B.C., Fan, M.Y., Devries, A., Braden, J.B., & Sullivan, M.D. (2010). Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study. Drug and Alcohol Dependence, 112, 90–98
   PubMed Web of Science ®Google Scholar
• Expert Working Group on Narcotic Addiction. (2012). The way forward: Stewardship for prescription narcotics in Ontario. Ontario: Ontario Ministry of Health and Long-Term Care
   Google Scholar
• Fischer, B., & Argento, E. (2012). Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician, 15, ES191–ES203
   PubMed Web of Science ®Google Scholar
• Fischer, B., Bibby, M., & Bouchard, M. (2010). The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of sourcing routes and control measures. Addiction, 105, 2062–2070
   PubMed Web of Science ®Google Scholar
• Fischer, B., Ialomiteanu, A., Boak, A., Adlaf, E., Rehm, J., & Mann, R. (2013). Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug and Alcohol Review, 32, 276–287
   PubMed Web of Science ®Google Scholar
• Fischer, B., Jones, W., & Rehm, J. (2013). High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005–2009. Pharmacoepidemiology and Drug Safety, 22, 438–442
   PubMed Web of Science ®Google Scholar
• Fischer, B., Keates, A., Bühringer, G., Reimer, J., & Rehm, J. (2014). Prescription opioid misuse: Why so markedly higher in North America compared to the rest of the world? Addiction, 109, 177–181
   PubMed Web of Science ®Google Scholar
• Fischer, B., Lusted, A., Roerecke, M., Taylor, B., & Rehm, J. (2012). The prevalence of mental health and pain symptoms in general population samples reporting non-medical use of prescription opioids: A systematic review and meta-analysis. Journal of Pain, 13, 1029–1044
   PubMed Web of Science ®Google Scholar
• Fishbain, D.A., Cole, B., Lewis, J., Rosomoff, H.L., & Rosomoff, R.S. (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine, 9, 444–459
   PubMed Web of Science ®Google Scholar
• Franklin, G.M., Mai, J., Turner, J., Sullivan, M., Wickizer, T., & Fulton-Kehoe, D. (2012). Bending the prescription opioid dosing and mortality curves: Impact of the Washington state opioid dosing guideline. American Journal of Industrial Medicine, 55, 325–331
   PubMed Web of Science ®Google Scholar
• Gomes, T., Juurlink, D.N., Moineddin, R., Gozdyra, P., Dhalla, I., Paterson, M., … Mamdani, M. (2011). Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthcare Quarterly, 14, 22–24
   PubMedGoogle Scholar
• Gomes, T., Redelmeier, D., Juurlink, D., Dhalla, I., Camacho, X., & Mamdani, M. (2013). Opioid dose and risk of road trauma in Canada A population-based study. JAMA Internal Medicine, 173, 196–201
   PubMed Web of Science ®Google Scholar
• Government of Canada. (2005). National framework for action to reduce the harms associated with alcohol and other drugs and substances in Canada: Answering the call (first edition). Ottawa, ON: Drug Strategy and Controlled Substances Programme and Canadian Centre on Substance Abuse
   Google Scholar
• Green, T.C., Heimer, R., & Grau, L.E. (2008). Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction, 103, 979–989
   PubMed Web of Science ®Google Scholar
• Hemenway, D. (2001). The public health approach to motor vehicles, tobacco, and alcohol, with applications to firearms policy. Journal of Public Health Policy, 22, 381–402
   PubMed Web of Science ®Google Scholar
• Herring, M.E., Shah, S.K., Shah, S.K., & Gupta, A.K. (2008). Current regulations and modest proposals regarding disposal of unused opiods and other controlled substances (special communication). The Journal of the American Osteopathic Association, 108, 338–343
   PubMedGoogle Scholar
• Hojsted, J., & Sjogren, P. (2007). Addiction to opioids in chronic pain patients: A literature review. European Journal of Pain (London, England), 11, 490–518
   PubMed Web of Science ®Google Scholar
• Jones, C.M., Mack, K.A., & Paulozzi, L.J. (2013). Pharmaceutical overdose deaths, United States, 2010. The Journal of the American Medical Association, 309, 657–659
   PubMed Web of Science ®Google Scholar
• Katz, N.P., Birnbaum, H.G., & Castor, A. (2010). Volume of prescription opioids used nonmedically in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 24, 141–144
   PubMedGoogle Scholar
• Kim, D., Irwin, K.S., & Khoshnood, K. (2009). Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health, 99, 402–407
   PubMed Web of Science ®Google Scholar
• Luger, L., Bathia, N., Alcorn, R., & Power, R. (2000). Involvement of community pharmacists in the care of drug misusers: Pharmacy-based supervision of methadone consumption. International Journal of Drug Policy, 11, 227–234
   PubMedGoogle Scholar
• Lynch, M.E., & Fischer, B. (2011). Prescription opioid abuse: What is the real problem and how do we fix it? Canadian Family Physician, 57, 1241–1242
   PubMed Web of Science ®Google Scholar
• Madadi, P., Hildebrandt, D., Lauwers, A.E., & Koren, G. (2013). Characteristics of opioid-users whose death was related to opioid-toxicity: A population-based study in Ontario, Canada. PLoS One, 8, e60600
   PubMed Web of Science ®Google Scholar
• Manchikanti, L., Helm, S., Fellows, B., Janata, J., Pampati, V., Grider, J., & Boswell, M.V. (2012). Opioid epidemic in the United States. Pain Physician, 15, ES9–ES38
   Google Scholar
• Mendelson, J., Flower, K., Pletcher, M., & Galloway, G. (2008). Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine. Experimental & Clinical Psychopharmacology, 16, 435–441
   PubMed Web of Science ®Google Scholar
• Modarai, F., Mack, K., Hicks, P., Benoit, S., Park, S., Jones, C., … Paulozzi, L. (2013). Relationship of opioid prescription sales and overdoses, North Carolina. Drug and Alcohol Dependence, 132, 81–86
   PubMed Web of Science ®Google Scholar
• National Advisory Committee on Prescription Drug Misuse. (2013). First do no harm: Responding to Canada's prescription drug crisis. Ottawa, ON: Canadian Centre on Substance Abuse. Retrieved from http://www.ccsa.ca/2013%20CCSA%20Documents/Canada-Strategy-Prescription-Drug-Misuse-Report-en.pdf?utm_source=NR&utm_medium=NewsRelease&utm_campaign=Rx2013
   Google Scholar
• Office of the Chief Coroner of Ontario. (2012). Office of the chief coroner report for 2009–2011. Toronto, ON: Ministry of Community Safety and Correctional Services. Retrieved from http://www.mcscs.jus.gov.on.ca/stellent/groups/public/@mcscs/@www/@com/documents/webasset/ec161620.pdf
   Google Scholar
• Paulozzi, L., Kilbourne, E.M., & Desai, H.A. (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine, 12, 747–754
   PubMed Web of Science ®Google Scholar
• Potter, J.S., Marino, E.N., Hillhouse, M.P., Nielsen, S., Wiest, K., Canamar, C.P., … Ling, W. (2013). Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from starting treatment with agonist replacement therapies (START). Journal of Studies on Alcohol and Drugs, 74, 605–613
   PubMed Web of Science ®Google Scholar
• Rehm, J., Shield, K.D., Gmel, G., Rehm, M.X., & Frick, U. (2013). Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. European Neuropsychopharmacology, 23, 89–97
   PubMed Web of Science ®Google Scholar
• Reifler, L.M., Droz, D., Bailey, J.E., Schnoll, S.H., Fant, R., Dart, R.C., … Baertelson, B.B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine, 13, 434–442
   PubMed Web of Science ®Google Scholar
• Room, R., Babor, T., & Rehm, J. (2005). Alcohol and public health. The Lancet, 365, 519–530
   PubMed Web of Science ®Google Scholar
• Schneider, J.P., Matthews, M., & Jamison, R.N. (2010). Abuse-deterrent and tamper-resistant opioid formulations: What is their role in addressing prescription opioid abuse? CNS Drugs, 24, 805–810
   PubMed Web of Science ®Google Scholar
• Seal, K., Downing, M., Kral, A., Singleton-Banks, S., Hammond, J., Lorvick, J., … Edlin, B.R. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco bay area. Journal of Urban Health, 80, 291–301
   PubMed Web of Science ®Google Scholar
• Sigmon, S.C., Dunn, K.E., Badger, G.J., Heil, S.H., & Higgins, S.T. (2009). Brief buprenorphine detoxification for the treatment of prescription opioid dependence: A pilot study. Addictive Behaviors, 34, 304–311
   PubMed Web of Science ®Google Scholar
• Sigmon, S.C., Dunn, K.E., Saulsgiver, K., Patrick, M.E., Badger, G.J., Heil, S.H., … Higgins, S.T. (2013). A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry, 70, 1347–1354
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). (2012). Results from the 2011 national survey on drug use and health: Detailed tables. Retrieved November 25, 2012, from http://www.samhsa.gov/data/NSDUH/2011SummNatFindDetTables/NSDUH-DetTabsPDFWHTML2011/2k11DetailedTabs/Web/HTML/NSDUH-DetTabsLOTSect1pe2011.htm#TopOfPage
   Google Scholar
• The Health Officers Council of British Columbia. (2011). Public health perspectives for regulating psychoactive substances. Vancouver, BC: The Health Officers Council of British Columbia
   Google Scholar
• Trescot, A.M., Boswell, M.V., Atluri, S.L., Hansen, H.C., Deer, T.R., Abdi, S., … Manchikanti, L. (2006). Opioid guidelines in the management of chronic non-cancer pain. Pain Physician, 9, 1–39
   PubMedGoogle Scholar
• Trescot, A.M., Glaser, S.E., Hansen, H., Benyamin, R., Patel, S., & Manchikanti, L. (2008). Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician, 11, S181–S200
   PubMed Web of Science ®Google Scholar
• Turk, D.C., Swanson, K.S., & Gatchel, R.J. (2008). Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. The Clinical Journal of Pain, 24, 497–508
   PubMed Web of Science ®Google Scholar
• Veilleux, J.C., Colvin, P.J., Anderson, J., York, C., & Heinz, A.J. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30, 155–166
   PubMed Web of Science ®Google Scholar
• Vernick, J.S., & Teret, S.P. (2000). A public health approach to regulating firearms as consumer products. University of Pennsylvania Law Review, 148, 1193–1211
   Web of Science ®Google Scholar
• Volkow, N.D., & McLellan, T.A. (2011). Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. The Journal of the American Medical Association, 305, 1346–1347
   PubMed Web of Science ®Google Scholar
• Walley, A.Y., Xuan, Z., Hackman, H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., …, Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ (Clinical Research Ed.), 346, f174
   PubMed Web of Science ®Google Scholar
• Wang, J., & Christo, P. (2009). The influence of prescription monitoring programs on chronic pain management. Pain Physician, 12, 507–515
   PubMed Web of Science ®Google Scholar
• Webster, L.R., Bath, B., & Medve, R.A. (2009). Opioid formulations in development designed to curtail abuse: Who is the target? Expert Opinion on Investigational Drugs, 18, 255–263
   PubMed Web of Science ®Google Scholar
• Webster, L.R., Cochella, S., Dasgupta, N., Fakata, K.L., Fine, P.G., Fishman, S.M., … Wakeland, W. (2011). An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Medicine, 12, S26–S35
   PubMed Web of Science ®Google Scholar
• Weiss, R.D., Potter, J.S., Fiellin, D.A., Byrne, M., Connery, H.S., Dickinson, W., … Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68, 1238–1246
   PubMed Web of Science ®Google Scholar
• Wisniewski, A.M., Purdy, C.H., & Blondell, R.D. (2008). The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. Journal of Addictive Diseases, 27, 1–11
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2010). Global strategy to reduce the harmful use of alcohol. Geneva, Switzerland: World Health Organisation
   Google Scholar
• Wunsch, M.J., Nakamoto, K., Behonick, G., & Massello, W. (2009). Opioid deaths in rural Virginia: A description of the high prevalence of accidental fatalities involving prescribed medications. The American Journal on Addictions, 18, 5–14
   PubMed Web of Science ®Google Scholar